Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -67.041% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CC(CN1C(=O)/C(=C/c2ccc(C#N)cc2)NC1=S)Cn1ccnc1
b.) COc1ccc(N2CCN(C(=O)COc3ncnc4ccccc34)CC2)cc1
Answer: a. CC(CN1C(=O)/C(=C/c2ccc(C#N)cc2)NC1=S)Cn1ccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(CN1C(=O)/C(=C/c2ccc(C#N)cc2)NC1=S)Cn1ccnc1
CC(CN1C(=O)/C(=C/c2ccc(C#N)cc2)NC1=S)Cn1ccnc1
4-[(Z)-[1-(3-imidazol-1-yl-2-methylpropyl)-5-oxo-2-sulfanylideneimidazolidin-4-ylidene]methyl]benzonitrile